Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
N-terminal pro-brain natriuretic peptide (NT-proBNP) is a non-active peptide fragment derived by cleavage of proBNP in cardiomyocytes in response to myocardial wall stress. While NT-proBNP itself does not exert biological effects, its concentration in plasma correlates closely with cardiac function, and it is extensively used in clinical practice as a biomarker for heart failure diagnosis, prognosis, and monitoring, as well as risk stratification for cardiovascular and some cerebrovascular events. Clearance is primarily renal, and levels are affected by kidney function, age, and other systemic conditions.
Not applicable; NT-proBNP is not a direct drug target. Its levels reflect cardiac wall stress and neurohormonal activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-terminal pro-brain natriuretic peptide (NT-proBNP).